Maksim Mamonkin

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2015-2023
Publications (10 Years): 5

Top Topics

Acute Lymphoblastic Leukemia

Top Venues

Nature biotechnology

Nature medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Dimitrios Laurin Wagner, Maksim Mamonkin
Splendid isolation. Blood 141 (22) (2023)
Mireya Paulina Velasquez, Maksim Mamonkin
CD7 CAR: sword and shield. Blood 140 (4) (2022)
Feiyan Mo, Norihiro Watanabe, Mary K McKenna, M John Hicks, Madhuwanti Srinivasan, Diogo Gomes-Silva, Erden Atilla, Tyler Smith, Pinar Ataca Atilla, Royce Ma, David Quach, Helen E Heslop, Malcolm K Brenner, Maksim Mamonkin
Engineered off-the-shelf therapeutic T cells resist host immune rejection. Nature biotechnology 39 (1) (2020)
Maksim Mamonkin, Helen E Heslop
Exhausting alloreactivity of donor-derived CAR T cells. Nature medicine 23 (2) (2019)
Diogo Gomes-Silva, Madhuwanti Srinivasan, Sandhya Sharma, Ciaran M Lee, Dimitrios L Wagner, Timothy H Davis, Rayne H Rouce, Gang Bao, Malcolm K Brenner, Maksim Mamonkin
CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies. Blood 130 (3) (2017)
Maksim Mamonkin, Rayne H Rouce, Haruko Tashiro, Malcolm K Brenner
A T-cell-directed chimeric antigen receptor for the selective treatment of T-cell malignancies. Blood 126 (8) (2015)